Exane Derivatives’s BlackLine BL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.53K Sell
23
-2,155
-99% -$148K ﹤0.01% 466
2022
Q1
$159K Sell
2,178
-247
-10% -$20K 0.04% 386
2021
Q4
$251K Buy
+2,425
New +$281K 0.06% 297

Other funds holding BL

Exane Derivatives's BL Position: Q2 2022 in Review

Exane Derivatives reduced its BlackLine (BL) stake by 99% in Q2 2022, selling an estimated $148K and leaving 23 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Exane Derivatives first reported a position in BL in Q4 2021 and has held it in 3 quarters since. The position peaked at $251K in Q4 2021. 305 funds tracked by Wall St. Rank hold BL as of Q2 2022.

  • Exane Derivatives held 23 shares of BlackLine worth $1.53K as of Q2 2022.
  • Exane Derivatives sold 2,155 BlackLine shares in Q2 2022, an estimated $148K.
  • BlackLine made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #466 holding.
  • Exane Derivatives first reported a position in BlackLine in Q4 2021 and has held it in 3 quarters since.
  • Exane Derivatives's BlackLine position peaked at $251K in Q4 2021.
  • 305 funds tracked by Wall St. Rank held BlackLine as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.